AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2021
Nov 29, 2021
32093_dirs_2021-11-29_c6396256-299a-4f72-9d42-889b6932f787.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2021-11-24
Reporting Person: Spray Shelley D (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-24 | Stock Option (right to buy) | $21.70 | A | 32500 | Acquired | 2031-11-24 | Common Stock (32500) | Direct |
Footnotes
F1: One-third (1/3) of the shares subject to the option will vest on November 24, 2022, and the remaining shares will vest in equal monthly installments thereafter over the following two-year period, subject to the Reporting Person's continued service through each vesting date.
More from PULSE BIOSCIENCES, INC.
Regulatory Filings
2026
Jun 10
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Capital/Financing Update
2026
May 6
Earnings Release
2026
May 4
Investor Presentation
2026
Apr 27
Investor Presentation
2026
Apr 16
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 7
Board/Management Information
2026
Mar 27